Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.25 USD | -0.19% | -1.07% | +507.92% |
04-02 | North American Morning Briefing : Stocks Seen -2- | DJ |
04-01 | HC Wainwright Downgrades Landos Biopharma to Neutral From Buy | MT |
Business Summary
Number of employees: 19
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gregory Oakes
CEO | Chief Executive Officer | 56 | 22-06-20 |
Claudia Lopez
CTO | Chief Tech/Sci/R&D Officer | - | 22-12-31 |
Dawn Louro
CTO | Chief Tech/Sci/R&D Officer | - | 22-03-31 |
Fabio Cataldi
CTO | Chief Tech/Sci/R&D Officer | 57 | 22-09-04 |
Tim Mayleben
BRD | Director/Board Member | 63 | 21-05-12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 57 | 17-08-31 | |
Tim Mayleben
BRD | Director/Board Member | 63 | 21-05-12 |
Alka Batycky
BRD | Director/Board Member | 54 | 23-05-29 |
Gregory Oakes
CEO | Chief Executive Officer | 56 | 22-06-20 |
Tiago Girão
BRD | Director/Board Member | 44 | 21-04-07 |
Roger Adsett
BRD | Director/Board Member | 55 | 22-03-07 |
Director/Board Member | 56 | 21-08-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,125,841 | 1,329,758 ( 42.54 %) | 0 | 42.54 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+507.92% | 69.68M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- LABP Stock
- Company Landos Biopharma, Inc.